Delivery Order SPE2DB22D1103-SPE2DB24FTFT0
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,770.74 order is for the supply of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, as the prime contractor, does not have a set-aside designation for this order. However, the company holds...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a potential value of $1,947.99 and a completion date of January 4, 2024. No set-aside designation was used for this award. As a prime contractor, Amerisourcebergen Drug Corp has an established history of providing pharmaceuticals, medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, with a potential value of $11,082.96 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. The company has an indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,916.62 order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a potential value of $3,351.28 and a period of performance through January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $20,014.44 order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. This delivery order is placed under an indefinite delivery contract (IDC) previously awarded to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The award has a potential value of $6,386.26 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and there is no set-aside designation. This delivery order is issued...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to support military treatment programs and facilities. The delivery order has a ceiling value of $27,757.07 and a completion date of March 1, 2022....
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $13,116.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for providing the pharmaceutical product to support military treatment programs and facilities. This delivery order is part of a larger...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a completion date of February 7, 2024 and a potential value of $3,502.35. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not designated as a set-aside contract. Amerisourcebergen Drug...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFT0Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $2,770.74, is for the supply of HUMIRA(CF) PEN 40 MG/0.4 ML pharmaceutical product. The order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) held by the company with DLA valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 2/27/24 |